Bryan Stuart
2023
In 2023, Bryan Stuart earned a total compensation of $1.9M as Former President and Chief Executive Officer at Fulcrum Therapeutics, a 53% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,294,861 |
|---|---|
| Salary | $2,385 |
| Other | $572,450 |
| Total | $1,869,696 |
Stuart received $1.3M in option awards, accounting for 69% of the total pay in 2023.
Stuart also received $2.4K in salary and $572.5K in other compensation.
Rankings
In 2023, Bryan Stuart's compensation ranked 567th out of 2,790 executives tracked by ExecPay. In other words, Stuart earned more than 79.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 567 out of 2,790 | 80th |
Division Manufacturing | 324 out of 1,530 | 79th |
Major group Chemicals And Allied Products | 227 out of 869 | 74th |
Industry group Drugs | 224 out of 832 | 73rd |
Industry Pharmaceutical Preparations | 140 out of 597 | 77th |
Source: SEC filing on April 19, 2024.
Stuart's colleagues
We found five more compensation records of executives who worked with Bryan Stuart at Fulcrum Therapeutics in 2023.
2023
Alex Sapir
Fulcrum Therapeutics
Chief Executive Officer
2023
Curtis Oltmans
Fulcrum Therapeutics
Chief Legal Officer
2023
Mel Hayes
Fulcrum Therapeutics
Executive Vice President, Patient Affairs
2023
Alan Musso
Fulcrum Therapeutics
Chief Financial Officer
2023
Robert Gould
Fulcrum Therapeutics